Home › Meningioma › Tennessee
Meningioma clinical trials in Tennessee
4 studies for Meningioma are looking for participants at sites in Tennessee.
Cities in Tennessee
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
- Vanderbilt University Medical Center, Nashville
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07493447Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Vanderbilt-Ingram Cancer Center, Nashville
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Oct 13, 2026 · NCT05636618Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- CHI Memorial Hospital, CommonSpirit, Chattanooga
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05425004From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.